Procter & Gamble
PG
$149.98
-1.00%
Procter & Gamble is a global consumer products giant manufacturing household essentials like Tide, Charmin, Pantene, and Pampers, operating in the Household & Personal Products industry. As one of the world's largest consumer product manufacturers with over 20 billion-dollar brands and annual sales near $85 billion, it holds a dominant market position through brand power and distribution scale. The current investor narrative centers on P&G's ability to sustain growth amid inflationary pressures and shifting consumer preferences, with recent quarterly results showing a 7.4% revenue increase and steady margin performance, while the stock's defensive qualities are being weighed against a broader market rotation into value.…
PG
Procter & Gamble
$149.98
Related headlines
Investment Opinion: Should I buy PG Today?
Rating: Buy. PG is a high-quality defensive stock with strong brand moats, consistent cash flows, and a growing dividend, making it suitable for long-term income-oriented investors. The consensus analyst rating is Buy with an average target of $163.43, implying 10.4% upside from $148.05. Supporting evidence: PG's trailing P/E of 23.89x is above the sector average but justified by its ROE of 30.71% and net margin of 18.69%. Revenue grew 7.38% YoY in Q3, and free cash flow of $15.028B TTM covers dividends and capex comfortably. The dividend yield of 2.52% is attractive, and the payout ratio of 61.8% leaves room for growth. The PEG ratio of 3.01x suggests the stock is not cheap, but the stability of earnings warrants a premium. Risks: The biggest risk is continued revenue deceleration, which could compress the P/E multiple. If growth falls below 5%, the stock could drop to $145 (analyst low). A sharp rise in interest rates could also pressure the valuation. This Buy rating would downgrade to Hold if the P/E expands above 28x or if free cash flow declines by more than 10%. Overall, PG is fairly valued relative to its history but slightly overvalued versus the sector; however, its defensive qualities and dividend growth justify a Buy for long-term investors.
Sign up to view all
PG 12-Month Price Forecast
PG's investment case is supported by strong fundamentals, including double-digit ROE, stable margins, and robust free cash flow. The stock's defensive nature and dividend yield make it attractive in uncertain markets, but the premium valuation and decelerating growth limit upside. The base case of gradual appreciation toward the analyst target is most likely, with a 55% probability. We would upgrade to more bullish if revenue growth re-accelerates above 8% or if the P/E compresses below 22x, offering a better entry. Conversely, a sustained drop in margins or a recession would shift us to neutral.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Procter & Gamble's 12-month outlook, with a consensus price target around $163.43 and implied upside of +9.0% versus the current price.
Average Target
$163.43
0 analysts
Implied Upside
+9.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$145 - $186
Analyst target range
PG is covered by 23 analysts, with a consensus recommendation of 'Buy' (mean score 2.04 on a 1-5 scale where 1 is Strong Buy). The average target price is $163.43, implying approximately +10.4% upside from the current price of $148.05. The distribution shows a bullish tilt, with recent ratings from B of A Securities (Buy), UBS (Buy), and JP Morgan (Overweight) reinforcing positive sentiment, while a few firms like Evercore ISI (In Line) and Barclays (Equal Weight) are more neutral. The target range spans from a low of $145.00 to a high of $186.00. The low target of $145.00 is slightly below the current price, suggesting some analysts see limited downside but also limited near-term catalysts. The high target of $186.00 implies a 25.6% upside, likely assuming margin expansion, successful innovation, or a valuation re-rating. The spread between low and high ($41) is moderate, reflecting reasonable uncertainty but not extreme divergence. Recent analyst actions have been predominantly reaffirmations of existing ratings, with no major downgrades, indicating stable conviction. The consensus leans bullish, supported by PG's defensive qualities and consistent dividend growth, though the modest upside to the average target suggests the stock is fairly valued rather than a deep value opportunity.
Drowning in data?
Find the real signal!
Bulls vs Bears: PG Investment Factors
PG presents a balanced risk/reward profile typical of a defensive consumer staple. The bull case rests on strong brand power, robust margins, and reliable cash flows that support a growing dividend, while the bear case highlights decelerating growth, premium valuation, and persistent market underperformance. Currently, the evidence slightly favors the bull case given the analyst consensus Buy and 10.4% upside to target, but the key tension is whether PG can re-accelerate revenue growth to justify its P/E premium. If growth stabilizes or improves, the stock could re-rate higher; if it continues to decelerate, valuation compression could erase upside.
Bullish
- Strong Brand Portfolio and Pricing Power: PG owns over 20 billion-dollar brands like Tide and Pampers, enabling consistent pricing power. Q3 FY2026 revenue grew 7.38% YoY to $21.235 billion, demonstrating ability to pass costs to consumers.
- Robust Profitability and Margins: Net margin of 18.69% and ROE of 30.71% are exceptional for consumer staples. Gross margin improved to 49.51% in Q3 from 49.11% in Q4 FY2025, reflecting easing input costs and productivity gains.
- Strong Free Cash Flow and Dividend: TTM free cash flow of $15.028 billion provides ample coverage for dividends ($2.53B in Q3) and capex. Dividend yield of 2.52% is attractive for income investors, with a payout ratio of 61.8%.
- Analyst Consensus Buy with Upside: 23 analysts rate PG a Buy (mean 2.04/5), with average target $163.43 implying 10.4% upside. High target of $186 suggests 25.6% potential return, supported by recent upgrades from BofA and UBS.
Bearish
- Decelerating Revenue Growth: Revenue declined sequentially from $22.386B in Q1 to $21.235B in Q3 FY2026, and YoY growth slowed from 8-10% to 7.38%. This trend suggests volume weakness and currency headwinds.
- Premium Valuation Limits Upside: Trailing P/E of 23.89x is above the consumer staples average of 18-22x. PEG ratio of 3.01x indicates the stock is expensive relative to its expected earnings growth, leaving little room for multiple expansion.
- Low Current Ratio and Liquidity Risk: Current ratio of 0.70 and quick ratio of 0.53 are low, indicating potential short-term liquidity stress. While typical for efficient working capital, it could become problematic if supply chain disruptions occur.
- Underperformance vs Market: PG's 1-year relative strength of -23.95% and 6-month relative strength of -6.69% show persistent underperformance. The stock is near the lower end of its 52-week range, suggesting weak momentum.
PG Technical Analysis
PG is in a range-bound consolidation phase, with the 1-year price change of -3.03% contrasting sharply with the S&P 500's +20.92% gain, indicating significant underperformance. The current price of $148.05 sits at 62% of its 52-week range ($137.62 low to $167.25 high), suggesting the stock is closer to the lower end of its yearly band and potentially offering a value entry if the downtrend reverses. The 1-year relative strength of -23.95% confirms persistent weakness versus the market. Short-term momentum shows a mixed picture: the 1-month change of -1.60% and 3-month change of +3.45% indicate a modest recovery from recent lows, but the 1-month relative strength of -2.20% still trails the market. The 6-month change of +2.44% is well below the S&P 500's +9.13%, highlighting that any bounce has been tepid. This divergence between the short-term uptick and long-term underperformance could signal a potential trend reversal if buying pressure builds, or simply a temporary pause in a broader downtrend. Key support lies at the 52-week low of $137.62, a break below which would signal further downside and potentially test the $130 area. Resistance is at the 52-week high of $167.25; a breakout above this level would indicate a strong reversal and renewed bullish momentum. With a beta of 0.38, PG is significantly less volatile than the market, making it a defensive holding that tends to decline less in downturns but also lag in rallies, which aligns with its recent underperformance.
Beta
0.38
0.38x market volatility
Max Drawdown
-16.1%
Largest decline past year
52-Week Range
$138-$167
Price range past year
Annual Return
-3.6%
Cumulative gain past year
| Period | PG Return | S&P 500 |
|---|---|---|
| 1m | -0.4% | +0.3% |
| 3m | +2.1% | +4.7% |
| 6m | +3.8% | +7.5% |
| 1y | -3.6% | +18.4% |
| ytd | +5.8% | +9.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PG Fundamental Analysis
Revenue growth has been steady but decelerating on a sequential basis: Q3 FY2026 (March 2026) revenue was $21.235 billion, up 7.38% year-over-year from $19.776 billion in Q3 FY2025, but down from $22.208 billion in Q2 FY2026 and $22.386 billion in Q1 FY2026. The Fabric Care & Home Care segment ($7.403 billion) and Baby, Feminine & Family Care ($5.058 billion) are the largest contributors, while Beauty ($3.866 billion) and Health Care ($3.073 billion) provide diversification. The growth trajectory remains positive but is slowing from the 8-10% range seen in earlier quarters, suggesting that volume gains and pricing power are being partially offset by currency headwinds and input cost inflation. Profitability is robust: net income for Q3 FY2026 was $3.968 billion, with a net margin of 18.69%, down slightly from 19.50% in Q2 but up from 17.31% in Q4 FY2025. Gross margin improved to 49.51% in Q3 from 49.11% in Q4 FY2025, reflecting easing commodity costs and productivity savings. Operating margin of 21.55% is healthy but below the 24.16% in Q2, indicating some cost pressure. The company remains highly profitable with consistent earnings, and margins are stable within a narrow range, typical for a mature consumer staples company. The balance sheet is solid: debt-to-equity ratio of 0.68 is moderate, and free cash flow for the trailing twelve months is $15.028 billion, providing ample coverage for dividends and capex. The current ratio of 0.70 is low, typical for consumer goods companies with efficient working capital management, but the quick ratio of 0.53 suggests limited short-term liquidity. Return on equity (ROE) of 30.71% is exceptional, reflecting strong profitability and efficient use of equity. The company generated $4.045 billion in operating cash flow in Q3, easily covering capital expenditures of $1.019 billion and dividends of $2.53 billion, demonstrating self-funding capacity.
Quarterly Revenue
$21.2B
2026-03
Revenue YoY Growth
+7.4%
YoY Comparison
Gross Margin
49.5%
Latest Quarter
Free Cash Flow
$15.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PG Overvalued?
Since net income is positive ($3.968 billion), the primary valuation metric is the P/E ratio. The trailing P/E is 23.89x, while the forward P/E is 20.98x, implying the market expects earnings growth of about 14% over the next year. The gap between trailing and forward P/E suggests that analysts anticipate a meaningful earnings recovery, which is consistent with the estimated EPS growth. Compared to the industry average (not provided, but consumer staples typically trade at 18-22x), PG's trailing P/E of 23.89x appears at a premium, likely justified by its strong brand portfolio, consistent margins, and reliable dividend growth. The PEG ratio of 3.01x indicates that the stock is priced at a premium to its expected earnings growth rate, suggesting it may be fully valued relative to growth. Historically, PG's trailing P/E has ranged from roughly 19x to 31x over the past five years. The current 23.89x is near the middle of this range, below the highs of 31x seen in mid-2024 but above the lows of 19x in late 2023. This mid-range valuation suggests the market is pricing in a balanced outlook—neither overly optimistic nor pessimistic. The P/B ratio of 7.52x is near the high end of its historical range (6.4x to 8.8x), indicating that the market is assigning a premium to the company's book value, likely due to its strong intangible assets and brand equity.
PE
23.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 19x~31x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: PG's debt-to-equity ratio of 0.68 is moderate, but the current ratio of 0.70 and quick ratio of 0.53 indicate limited short-term liquidity, which could be strained if a recession hits consumer spending. Operating margin declined from 24.16% in Q2 to 21.55% in Q3 FY2026, signaling cost pressures from inflation and currency headwinds. The sequential revenue decline from $22.386B to $21.235B raises concerns about volume trends, especially in the Fabric Care and Baby segments. Free cash flow of $15.028B TTM is strong, but any sustained margin compression would directly impact dividend growth. Market & Competitive Risks: PG's trailing P/E of 23.89x is at a premium to the consumer staples sector average of 18-22x, making it vulnerable to multiple compression if interest rates remain high. The stock's beta of 0.38 limits downside but also caps upside in rallies, as evidenced by its 1-year relative strength of -23.95%. Competition from private labels and smaller brands could erode market share, especially if consumers trade down. Recent news about Europe's energy crisis may pressure input costs, while rotation from growth to value could benefit PG but has yet to materialize. Worst-Case Scenario: A prolonged recession could cause consumers to trade down to cheaper alternatives, compressing PG's margins and revenue. If the stock falls to its 52-week low of $137.62, that represents a -7.05% decline from the current price of $148.05. In a severe downturn, the stock could test $130 (historical support), implying a -12.2% loss. The analyst low target of $145 suggests limited downside, but a break below $137.62 would signal further weakness.
FAQ
The key risks are: (1) Revenue deceleration—sequential revenue declined from $22.386B in Q1 to $21.235B in Q3 FY2026, and YoY growth slowed to 7.38%. (2) Valuation compression—the trailing P/E of 23.89x is above the sector average, and if growth disappoints, the multiple could contract to 20x, pushing the stock to $138. (3) Input cost inflation—gross margin improved but remains sensitive to commodity prices; a spike could pressure profitability. (4) Low liquidity ratios—current ratio of 0.70 and quick ratio of 0.53 indicate potential short-term stress, though typical for the industry. The most severe risk is a recession causing consumer trade-down, which could cut revenue growth below 4% and trigger a -7% decline to the 52-week low of $137.62.
The 12-month forecast is moderately bullish. The base case (55% probability) sees PG trading between $148 and $163, driven by steady revenue growth of 5-7% and stable margins, gradually moving toward the analyst average target of $163.43. The bull case (25% probability) targets $163-$186, assuming a defensive rotation and margin expansion. The bear case (20% probability) sees the stock falling to $138-$145 if a recession hits or margins compress. The most likely scenario is the base case, with the stock offering a 10.4% total return (price appreciation plus dividend) over the next year. Key assumptions include gross margins staying above 49% and revenue growth not falling below 5%.
PG's trailing P/E of 23.89x is above the consumer staples sector average of 18-22x, suggesting it is slightly overvalued relative to peers. However, its ROE of 30.71% and net margin of 18.69% are best-in-class, justifying a premium. The PEG ratio of 3.01x indicates the stock is expensive relative to its expected earnings growth of ~8% per year. Historically, PG's P/E has ranged from 19x to 31x over the past five years; the current 23.89x is near the middle, implying fair valuation. The P/B ratio of 7.52x is near the high end of its historical range, reflecting strong brand equity. Overall, PG is fairly valued for its quality but not a bargain.
PG is a good buy for long-term, income-oriented investors seeking stability and reliable dividends. The stock offers a 2.52% dividend yield with a 61.8% payout ratio, supported by $15.028B in TTM free cash flow. Analyst consensus is Buy with an average target of $163.43, implying 10.4% upside from $148.05. However, the trailing P/E of 23.89x is above the consumer staples average, so it is not a deep value play. The biggest downside risk is continued revenue deceleration, which could push the stock to the analyst low of $145. For growth investors, PG may be too slow; but for those seeking a defensive anchor, it is a solid buy at current levels.
PG is best suited for long-term investment, with a recommended holding period of at least 3-5 years. The stock's beta of 0.38 makes it a low-volatility defensive holding, but it tends to lag in strong bull markets, as shown by its 1-year relative strength of -23.95%. Short-term traders may find limited upside due to the stock's range-bound nature and lack of catalysts. However, for long-term investors, PG's 2.52% dividend yield, consistent earnings growth, and strong free cash flow provide a reliable total return. The company's 30.71% ROE and 20+ billion-dollar brands ensure competitive advantages that compound over time. Short-term trading is not recommended due to low volatility and minimal price momentum.
